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strains was associated with increased 
isolate diversification (8), which sug-
gests a selective restriction of the dom-
inant circulating strain (2). In France, 
the W135/ST11 strain was rare after 
2005; no cases were culture confirmed 
in 2010, and the 2 cases that were con-
firmed in 2011 showed the FetA2-19 
marker. However, isolates from Africa 
during 2000–2011 frequently showed 
the FetA1 marker; in sub-Saharan Af-
rica, the decline of W135/ST11 isolates 
was also associated with isolates show-
ing diversified FetA markers (M.-K. 
Taha, unpub. data). The reemergence in 
2012 of W135/ST11 strains that had the 
FetA1-1 marker suggests an antigenic 
shift that may have involved membrane 
proteins other than FetA or other sur-
face structures, such as the lipooligo-
sasccharide. Such antigenic shifts were 
associated with increased incidence of 
serogroup C and serogroup Y meningo-
coccal disease in the United States (9). 
Antigenic shift could be a marker of 
changes in virulence and transmission 
of meningococcal isolates. Extensive 
molecular typing of meningococcal 
isolates is more likely to detect antigen-
ic shifts and escape variants that may 
undergo clonal expansion and therefore 
should be employed in outbreak inves-
tigations. Enhanced surveillance was 
setup in France to identify imported 
W135 cases.
Our findings indicate that travel-
ers to the meningitis belt of sub-Sa-
haran Africa may be at risk for infec-
tion with N. meningitidis of serogroup 
W135. A vaccination campaign using 
the meningococcal A conjugate vac-
cine is ongoing in this region (10), 
but a conjugate bivalent vaccine that 
includes W135 should also be consid-
ered. Vaccination of travelers to this 
region with quadrivalent meningococ-
cal vaccine should be recommended. 
Information regarding the patients and 
their contacts were provided by the clini-
cians, the French Institute for Public Health 
Surveillance (wwwinvs.sante.fr), and the 
Regional Health Agencies of Pays-de-
Loire, Rhône-Alpes and Ile-de-France. In 
Côte d’Ivoire, the work was supported by 
the Agence Médecine Préventive and the 
mobile laboratory; patient information was 
provided by clinicians at health districts 
and the National Institute of Public Health.
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Clostridium difficile 
Infection Associated 
with Pig Farms
To the Editor: Clostridium diffi-
cile of PCR ribotype 078 causes enteric 
disease in humans and pigs (1,2); a re-
cent pan-European study revealed that 
this type was the third most frequently 
found type of C. difficile (1). The find-
ing of identical C. difficile PCR ribo-
type 078 isolates in piglets with diar-
rhea and in humans with C. difficile 
infection (CDI) led to the suggestion 
that interspecies transmission might 
occur (3,4). Because C. difficile can be 
detected in the immediate environment 
of pig farms, we investigated intestinal 
colonization with C. difficile in pigs 
and in pig farmers, their relatives, and 
their employees in the Netherlands.
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Persons living on 32 pig farms 
were enrolled as part of a longitudi-
nal intervention study of several zoo-
notic agents. Pig farmers were partly 
recruited through the Dutch Farmer’s 
Association or by veterinarians, who 
informed potential participants about 
the aims of the study. Inclusion criteria 
for participants were that they should 
work and/or live on the farm; the farms 
were either closed farms or multipliers 
(farms at which piglets are bred and 
then sold to other farms, where they 
are raised until ready for slaughter). 
The number of persons willing to sub-
mit a fecal sample per farm ranged 
from 1 to 10 (mean 4, median 5). Vet-
erinarians who normally provided vet-
erinary services to each farm collected 
fresh fecal samples from the floors of 
10 animal wards per farm. No a priori 
knowledge of C. difficile colonization 
status of the pigs on the farms was 
available. Fecal samples from humans 
and from animal wards were cultured 
for the presence of toxinogenic C. dif-
ficile by using previously described 
methods (1,3,4).
Of the 128 persons who enrolled 
in the study, 48 had daily contact with 
pigs, 22 had weekly contact with pigs, 
and 36 had contact with pigs varying 
from monthly to less than yearly; 
no contact information was avail-
able for 22 participants. A total of 12 
(25%) of 48 persons who had daily 
contact with pigs had fecal samples 
positive for C. difficile colonization; 
for persons who had weekly contact 
with pigs, 3 (14%) of 22 had posi-
tive samples. Daily to weekly contact 
with pigs versus monthly to less than 
yearly contact was significantly as-
sociated with an intestinal presence 
of C. difficile (p = 0.003). C. difficile 
was also found in fecal samples from 
3 persons for whom no contact infor-
mation was available. The C. difficile 
carriage rate among those with daily 
to weekly contact with pigs (15/70, 
21%) was higher than the carriage 
rate of <5% reported for nonhospital-
ized adults with CDI (5).
A total of 18 C. difficile–positive 
human samples were detected at 16 
of 32 pig farms investigated. At 2 of 
these farms, only 1 person submitted a 
sample, but at the other 14 farms, the 
number of participants ranged from 2 
to 9 (mean 4, median 3). C. difficile 
was found in pig manure at all farms; 
10%–80% of the wards were positive 
per farm. 
Corresponding C. difficile PCR 
ribotypes were cultured from samples 
from pigs and humans; type 078 was 
found in humans and pigs on 15 farms 
and type 045 in a farmer and his pigs 
on 1 farm. Multilocus variable number 
tandem repeat analysis (MLVA) and 
antimicrobial drug susceptibility test-
ing (E-test) were performed on human 
isolates from 15 farms and 1 porcine 
isolate per farm. One human isolate 
could not be typed because the isolate 
was lost during laboratory activities.
MLVA results showed that, at 2 
farms, the human and porcine isolates 
were not genetically related, whereas 
at the other 13 farms, human and por-
cine isolates were genetically related, 
including 100% identical MLVA re-
sults for type 078 human and porcine 
isolates at 3 farms. Isolates were con-
sidered genetically related when the 
summed tandem repeat differences 
were <10 (3,4,6). 
Antimicrobial drug susceptibil-
ity testing demonstrated similar sus-
ceptibility levels among isolates. For 
human and porcine isolates from 9 of 
15 farms, MIC variability of <1 µg/L 
was found for imipenem, cotrimoxa-
zole, erythromycin, clindamycin, tet-
racycline, and moxifloxacin. For the 
remaining 6 farms, drug susceptibility 
patterns for human isolates differed 
from pig isolates for 1 drug only: for 1 
farm, MICs of erythromycin were 256 
µg/L for human isolates and 0.38 µg/L 
for pig isolates; for 3 farms, MICs of 
erythromycin were 256 µg/L for pig 
isolates and 0.25 µg/L for human iso-
lates; and for 2 farms, MICs of imipe-
nem were 32 µg/L for pig isolates and 
1.5 or 2 µg/L for human isolates. 
In summary, the high C. difficile 
carriage rate among persons who had 
direct contact with pigs and the fact 
that these C. difficile isolates were 
genotypically and phenotypically 
similar to the pig isolates from the 
same farms indicates that transmis-
sion occurs either by direct contact 
or through the environment. Prospec-
tive studies are needed to determine 
the relationship between C. difficile 
carriage and development of CDI in 
this population.
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Prolonged  
Incubation Period 
for Cryptococcus 
gattii Infection  
in Cat, Alaska, USA
To the Editor: We report a case 
of Cryptococcus gattii infection in 
a 12-year-old neutered male cat in 
Alaska. The cat traveled to Anchor-
age, Alaska (61°N) from San Diego 
County, California, with its owner in 
August 2003. Although C. gattii has 
not been detected in Alaska (where 
only extremely limited sampling has 
occurred) or above 49°N (i.e., Van-
couver Island, British Columbia), the 
case suggests that the incubation pe-
riod for C. gattii could be >8 years.
In September 2010, the cat was 
brought to a veterinary clinic in An-
chorage because of facial pruritis and 
excoriation. The cat did not respond 
to treatment with methylprednisolone 
acetate and was referred to a veteri-
nary dermatologist in October. At that 
time, alopecia, thick scaling, and ex-
coriations were observed on ear mar-
gins, sides of the head, and between 
the eyes. The hair coat was sparse, and 
there was minimal scaling near the 
tail and lower legs. All foot pads were 
excessively cross-hatched and scaly. 
Cytologic analysis of the skin on the 
head and pinna showed neutrophils and 
cocci overgrowth. Skin scrapings were 
negative for mites. Cytologic analysis 
of the ears did not identify yeast bod-
ies, parasites, or bacteria. A long-acting 
antimicrobial drug for treatment of skin 
infections (cefovecin) was given.
Biopsy specimens were obtained 
from the head, ears, and paws, and 
analysis of these samples supported 
a diagnosis of mural folliculitis and 
mild plasma cell pododermatitis. 
Chest radiograph findings and results 
of routine blood analysis were not un-
usual. Test results for feline leukemia 
virus and feline immunodeficiency vi-
rus were negative. Prednisolone (1.8 
mg/kg/d) was given; the cat showed a 
good response and eventual resolution 
of scaling. Hair grew back but the ste-
roid dose could not be reduced to <2.5 
mg/d because periodic increases were 
needed when symptoms flared.
In November 2011, the cat was 
brought back to the veterinary clinic 
because of worsening of the skin con-
dition even though the owner had in-
creased the prednisolone dose to 7.5 
mg/d during the previous 3 weeks. 
The cat had also started shaking its 
head frequently and had a unilateral 
right nasal discharge. Major nasal dis-
charge had not been a symptom pre-
viously reported by the owner. Cyto-
logic analysis of the discharge showed 
large yeast bodies consistent with a 
Cryptococcus sp. interspersed among 
neutrophils, cocci, and rods.
The cat was treated with flucon-
azole, and prednisolone was slowly 
decreased to minimal doses to control 
the mural folliculitis. After consulta-
tion with the Alaska Office of the State 
Veterinarian and Division of Public 
Health, a nasal swab specimen was 
sent to the Centers for Disease Con-
trol and Prevention (CDC) (Atlanta, 
GA, USA) for confirmation and mo-
lecular typing. Since 2009, Alaska has 
participated in the CDC-led Pacific 
Northwest C. gattii working group, 
which has been interested in enhanced 
surveillance for C. gattii (1,2). CDC 
identified the isolate as C. gattii mo-
lecular type VGIII; this type is com-
monly reported in the southern United 
States, particularly California (3).
Given what is known about the 
potential for dispersal of C. gattii (4), 
the owner was extensively interviewed 
about travel history of the cat and house-
hold members, and any travelers to or 
visitors from California who may have 
brought items into the house. The cat 
was rescued as a stray at ≈1 year of age 
in California, and after traveling to An-
chorage had lived as an indoor/outdoor 
cat without further travel. The family 
had not transported or received organic 
materials from California, except for 
an elongated (≈45 cm) seedpod. All 
plants and potting soil had been bought 
locally from national chain vendors. 
In May 2012, fifteen environmental 
samples, including soil from the yard, 
commercial potting soil, and a planter 
made from the seedpod brought from 
California, were taken from the home 
of the cat; all showed negative results 
for C. gattii when tested at CDC.
In humans, the average incuba-
tion period for C. gattii infection is 6 
weeks–13 months (5–7). Therefore, 
case-patients are usually asked to re-
call potential exposures during the 13 
months before symptom onset (5). Al-
though most reported cases of C. gattii 
infection appear to be primary infec-
tions, infrequent reports of C. gattii in-
fections in immunocompetent persons 
have described symptoms occurring 
several years after likely exposure, 
which suggests that C. gattii may have a 
greater capacity to remain dormant than 
believed (8–10). Incubation periods are 
not well described for animals but are 
generally reported as 2–11 months (R. 
Wohrle, pers. comm.). For either animal 
or human case-patients living in dis-
ease-endemic areas, precise incubation 
periods are likely incalculable because 
potential exposure to fungi is ongoing.
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